Palladin, Cytoskeletal Associated Protein (PALLD) (Middle Region) Peptid
PALLD
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN5673466
Kurzübersicht für Palladin, Cytoskeletal Associated Protein (PALLD) (Middle Region) Peptid (ABIN5673466)
Target
PALLD
(Palladin, Cytoskeletal Associated Protein (PALLD))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequenz
- RRPRSRSRDS GDENEPIQER FFRPHFLQAP GDLTVQEGKL CRMDCKVSGL
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- PALLD Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PALLD (Palladin, Cytoskeletal Associated Protein (PALLD))
-
Hintergrund
-
This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants.
Alias Symbols: MYN, PNCA1, CGI151, SIH002, CGI-151
Protein Size: 777 -
Gen-ID
- 23022
-
NCBI Accession
- NM_001166108, NP_001159580
Target
-
Sie sind hier:
